Bladder Cancer Doctors Worldwide

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Doctor Sefik Igdem specializes in Radiation Oncology with advanced technologies like Truebeam Stx and Halcyons.

• Over 30 years of experience in radiation oncology
• Specializes in head and neck cancers alongside bladder cancer
• Professor at T.R. Demiroğlu Bilim University
• Trained at Istanbul University – one of Turkey's top medical schools

Prof. Montorsi has performed over 8,000 urology surgeries, specializing in minimally invasive and robotic techniques for bladder cancer at San Raffaele.

• Director of the Urological Research Institute at Vita-Salute San Raffaele University
• Recipient of the Hugh Hampton Young Award for contributions to urologic oncology
• Published over 1,000 papers on urology and andrology
• Honorary fellowship from the Royal College of Surgeons of England

Dr. David Kuczer is a radiation oncologist at Amethyst Radiotherapy in Vienna. He specializes in precise cancer treatment for tumors of the prostate, breast, and brain. Dr. Kuczer presents every patient case to an interdisciplinary tumor board. This ensures each person receives a validated treatment plan from a team of experts.

• Uses the Elekta Versa HD linear accelerator for precise tumor targeting.
• Treats complex conditions including glioblastoma, lung cancer, and meningioma.
• Coordinates care within a clinic ranked among Newsweek's World's Best Hospitals 2026.
• Provides IMRT, VMAT, and stereotactic radiosurgery for high-accuracy radiation.

Dr. Mehmet Salih Iyikesici is a medical oncologist. His work focuses on metabolically supported chemotherapy (MSCT), ketogenic diet–supported cancer care, hyperthermia, hyperbaric oxygen therapy, and insulin potentiation therapy. He emphasizes care for breast, pancreatic, and gastric cancers.

He is a Medical Oncology Specialist at Neolife Medical Center (2026–present). He previously served at Private Bahçelievler Medical Park (2013–2026), Medicana Beylikdüzü (2010–2013), Silivri Anadolu (2009–2010), Diyarbakır Training and Research (2008–2009), and Bursa Çekirge State (2006–2008). Earlier, he worked as an Internal Medicine Specialist (1997–2003). He was an Assistant Professor at Altınbaş University (2014–2026).

Training: Medical Oncology subspecialty, Marmara University (2003–2006). Internal Medicine, Istanbul Haydarpaşa Numune (1992–1996). Medicine, Uludağ University (1985–1990). Member, Medical Oncology Association (since 2004). His recent research (2019–2020) covers gastric, breast, pancreatic, and lung cancers. Topics include long‑term survival in metastatic pancreatic cancer and feasibility in metastatic non‑small cell lung cancer (NSCLC).

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Dr. Shira Felder leads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior radiation oncologist specializing in gynecologic and urologic cancers. She trained at the Princess Margaret Cancer Centre in Toronto. Dr. Felder focuses on delivering targeted radiation while preserving her patients' quality of life.

• Uses precision techniques including VMAT, IMRT, SBRT, and brachytherapy.
• Treats cervical, uterine, ovarian, and prostate cancers.
• Maintains membership in the European Society for Radiotherapy & Oncology.
• Works at Sheba Medical Center, ranked 7th globally by Newsweek.
• Conducts research on brachytherapy safety and cervical cancer survival.

Performs over 500 urology surgeries, including minimally invasive procedures on the Da Vinci robotic system.

• 38 years as uro-oncologist and transplantologist
• Heads Urology Dept at Teknon Medical Center
• Specializes in prostate cancer and bladder conditions
• Treats congenital urological pathologies in children
• Member of European Urological Society

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Specialized in urogenital cancers at Anadolu Medical Center – over 29 years focused on bladder cancer treatments.

• Board-certified in medical oncology with advanced training at Cerrahpaşa Medical School
• Member of Turkish Medical Oncology Society and Lung Cancer Society
• Previously served at leading hospitals like Medical Park and research institutions
• Handles complex cases including urothelial carcinomas and metastatic disease

900+ procedures performed – Dr. Keskin specializes in personalized therapy for complex cancers at Memorial Şişli Hospital.

• 25 years of experience in medical oncology
• Internationally recognized expert in targeted therapies
• Ranked 1st in Turkey's Medical Oncology Proficiency Exam
• Member of ASCO and ESMO

Dr. Solak completed his fellowship at Hacettepe University Cancer Institute, specializing in complex oncology cases.

• Deals with various cancers including bladder, breast, and lung
• Trained at The University of Texas MD Anderson Cancer Center
• Specialized in oncology at Istanbul Sisli Etfal Training and Research Hospital
• Works at Hisar Hospital Intercontinental

Professor Yesim Yildirim is a specialist in immunotherapy and targeted treatments, which are key modern approaches to managing cancer. She has contributed to 80+ international scientific publications and textbooks.

• Professor of Medical Oncology at Haliç University
• Focuses on treating breast, lung, and gastrointestinal cancers
• Authoritative member of the European Society of Medical Oncology (ESMO)
• Trained at centers like Rambam Medical Centre in Israel
• Has worked as a medical oncologist at Anadolu Medical Center since 2011

Assoc. Prof. Dr. Heves Sürmeli is a specialist in Internal Medicine and Medical Oncology. She received her medical degree (M.D.) from Eskişehir Osmangazi University in 2004. She completed her Internal Medicine residency at Kartal Dr. Lütfi Kırdar Training and Research Hospital, Istanbul (2005–2010). She then completed subspecialty training in Medical Oncology at the same hospital (2014–2017).

At the same center, she served as a Medical Oncology Specialist (2017–2023). She then worked as Administrative and Clinical Director (2023–2026). Her clinical interests include breast, lung, gynecologic, gastrointestinal, and urologic cancers.

She has published many articles in international peer‑reviewed journals. She has presented at national and international conferences. She is active in professional societies. She has received several awards.

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Dr. Mehmet Dogu Canoglu is a radiation oncologist at Anadolu Medical Center in Istanbul. He specializes in precise tumor targeting using MR Linac and CyberKnife technologies. Dr. Canoglu trained at Kocaeli University. He previously served at Medipol Mega University Hospital. He treats various cancers, including complex brain, prostate, and lung tumors.

• Expert in Varian TrueBeam and Trilogy radiation delivery systems.
• Performs stereotaxic radiosurgery and targeted radiotherapy for sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.
• Treats patients at a clinic ranked among the world's top 10 for medical tourism.

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.